Guest guest Posted July 12, 2008 Report Share Posted July 12, 2008 Here's some information on Bortezomib (Velcade), a targeted therapy approved for Mantle cell lymphoma. .... describes possible synergy with dexamethasone. Seems a thorough outline of toxicities as well. http://www.communityoncology.net/journal/articles/0408480.pdf ~ Karl Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.